Search Results - "Feenstra, L."

Refine Results
  1. 1

    AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users by Vemer, P., Corro Ramos, I., van Voorn, G. A. K., Al, M. J., Feenstra, T. L.

    Published in PharmacoEconomics (01-04-2016)
    “…Background A trade-off exists between building confidence in health-economic (HE) decision models and the use of scarce resources. We aimed to create a…”
    Get full text
    Journal Article
  2. 2

    Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach by HOOGENDOORN, M, HOOGENVEEN, R. T, RUTTEN-VAN MÖLKEN, M. P, VESTBO, J, FEENSTRA, T. L

    Published in The European respiratory journal (01-03-2011)
    “…The aim of our study was to estimate the case fatality of a severe exacerbation from long-term survival data presented in the literature. A literature search…”
    Get full text
    Journal Article
  3. 3

    Stability of Ketoprofen Methylester in Plasma of Different Species by Hu, Steven X, Ernst, Kelsey, Benner, Charles P, Feenstra, Kenneth L

    Published in Current drug metabolism (01-01-2021)
    “…Pharmacokinetic and pharmacodynamic assessment of ester-containing drugs can be impacted by hydrolysis of the drugs in plasma samples post blood collection…”
    Get more information
    Journal Article
  4. 4

    Mapping chronic disease prevalence based on medication use and socio-demographic variables: an application of LASSO on administrative data sources in healthcare in the Netherlands by Füssenich, Koen, Boshuizen, Hendriek C, Nielen, Markus M. J, Buskens, Erik, Feenstra, Talitha L

    Published in BMC public health (02-06-2021)
    “…Abstract Background Policymakers generally lack sufficiently detailed health information to develop localized health policy plans. Chronic disease prevalence…”
    Get full text
    Journal Article
  5. 5

    More than cost‐effectiveness? Applying a second‐stage filter to improve policy decision making by Kan, Kaying, Jörg, Frederike, Lokkerbol, Joran, Mihalopoulos, Cathrine, Buskens, Erik, Schoevers, Robert A., Feenstra, Talitha L.

    “…Background Apart from cost‐effectiveness, considerations like equity and acceptability may affect health‐care priority setting. Preferably, priority setting…”
    Get full text
    Journal Article
  6. 6

    Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs: A multi-phase preclinical study by Feenstra, L.R., Gehring, R., van Geijlswijk, I.M., König, T., Prinsen, H.C.M.T., Vandemeulebroecke, K., Lammens, T., Krupa, A., Teske, E.

    Published in The veterinary journal (1997) (01-08-2022)
    “…L-asparaginase is a frequently used drug in the treatment of canine malignant lymphoma. Since production and availability of native E. coli-derived…”
    Get full text
    Journal Article
  7. 7

    Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD by Hoogendoorn, Martine, Feenstra, Talitha L, Hoogenveen, Rudolf T, Rutten-van Mölken, Maureen P M H

    Published in Thorax (01-08-2010)
    “…The aim of this study was to estimate the long-term (cost-) effectiveness of smoking cessation interventions for patients with chronic obstructive pulmonary…”
    Get more information
    Journal Article
  8. 8

    A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis by Suijkerbuijk, Anita W M, Over, Eelco A B, Opsteegh, Marieke, Deng, Huifang, Gils, Paul F van, Bonačić Marinović, Axel A, Lambooij, Mattijs, Polder, Johan J, Feenstra, Talitha L, Giessen, Joke W B van der, Wit, G Ardine de, Mangen, Marie-Josee J

    Published in PloS one (10-05-2019)
    “…In the Netherlands, toxoplasmosis ranks second in disease burden among foodborne pathogens with an estimated health loss of 1,900 Disability Adjusted Life…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Lifetime medical costs of obesity: prevention no cure for increasing health expenditure by van Baal, Pieter H M, Polder, Johan J, de Wit, G Ardine, Hoogenveen, Rudolf T, Feenstra, Talitha L, Boshuizen, Hendriek C, Engelfriet, Peter M, Brouwer, Werner B F

    Published in PLoS medicine (01-02-2008)
    “…Obesity is a major cause of morbidity and mortality and is associated with high medical expenditures. It has been suggested that obesity prevention could…”
    Get full text
    Journal Article
  11. 11

    Cost‐effectiveness of implant‐supported mandibular removable partial dentures by Jensen, Charlotte, Ross, Jamila, Feenstra, Talitha L., Raghoebar, Gerry M., Speksnijder, Caroline, Meijer, Henny J.A., Cune, Marco S.

    Published in Clinical oral implants research (01-05-2017)
    “…Objectives The aim of this study was to conduct a cost‐effectiveness analysis comparing conventional removable partial dentures (RPDs) and implant‐supported…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    A review of the current literature on management of halitosis by Van Den Broek, AMWT, Feenstra, L, De Baat, C

    Published in Oral diseases (01-01-2008)
    “…Halitosis is an unpleasant or offensive odour, emanating from the oral cavity. In approximately 80% of all cases, halitosis is caused by microbial degradation…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination of In Vitro Assays and Pharmacokinetic Data from the Literature by Hu, Steven X, Mazur, Chase A, Feenstra, Kenneth L

    Published in Drug metabolism letters (2019)
    “…There has been a lack of information about the inhibition of bovine medicines on bovine hepatic CYP450 at their commercial doses and dosing routes. The aim of…”
    Get more information
    Journal Article
  19. 19

    Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality by de Jong, L. A., Li, X., Emamipour, S., van der Werf, S., Postma, M. J., van Dijk, P. R., Feenstra, T. L.

    Published in PharmacoEconomics - open (01-11-2023)
    “…Introduction This review aims to critically appraise differences in methodology and quality of model-based and empirical-data-based cost-utility studies to…”
    Get full text
    Journal Article
  20. 20